A surgical strategy using a fusion image constructed from 11C-methionine PET, 18F-FDG-PET and MRI for glioma with no or minimum contrast enhancement

被引:11
|
作者
Ideguchi, Makoto [1 ]
Nishizaki, Takafumi [1 ]
Ikeda, Norio [1 ]
Okamura, Tomomi [1 ]
Tanaka, Yasue [1 ]
Fujii, Natsumi [1 ]
Ohno, Machiko [1 ]
Shimabukuro, Taichi [1 ]
Kimura, Tokuhiro [2 ]
Ikeda, Eiji [2 ]
Suga, Kazuyoshi [3 ]
机构
[1] Ube Kohsan Cent Hosp Corp, Dept Neurosurg, 750 Nishikiwa, Ube, Yamaguchi 7550151, Japan
[2] Yamaguchi Univ, Grad Sch Med, Dept Pathol, Ube, Yamaguchi, Japan
[3] St Hill Hosp, Dept Radiol, Ube, Yamaguchi, Japan
关键词
11C-methionine PET; F-18 fluorodeoxyglucose PET; Fence-post method; Tumor delineation; Non- or minimally enhancing glioma; POSITRON-EMISSION-TOMOGRAPHY; LOW-GRADE GLIOMA; GLIOBLASTOMA-MULTIFORME; F-18; FLUORODEOXYGLUCOSE; PROGNOSTIC-SIGNIFICANCE; C-11-METHIONINE PET; COMPUTED-TOMOGRAPHY; BRAIN-TUMORS; GA-68; EDTA; RESECTION;
D O I
10.1007/s11060-018-2821-9
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The objective of this study was to investigate the distribution of 11C-methionine (MET) and F-18 fluorodeoxyglucose (FDG) uptake in positron emission tomography (PET) imaging and the hyperintense area in T2 weighted imaging (T2WI) in glioma with no or poor gadolinium enhancement in magnetic resonance imaging (GdMRI). Cases were also analyzed pathologically. We prospectively investigated 16 patients with non- or minimally enhancing (< 10% volume) glioma. All patients underwent MET-PET and FDG-PET scans preoperatively. After delineating the tumor based on MET uptake, integrated 3D images from FDG-PET and MRI (GdMRI, T2WI or FLAIR) were generated and the final resection plane was planned. This resection plane was determined intraoperatively using the navigation-guided fencepost method. The delineation obtained by MET-PET imaging was larger than that with GdMRI in all cases with an enhanced effect. In contrast, the T2WI-abnormal signal area (T2WI+) tended to be larger than the MET uptake area (MET+). Tumor resection was > 95% in the non-eloquent area in 4/5 cases (80%), whereas 10 of 11 cases (90.9%) had partial resection in the eloquent area. In a case including the language area, 92% resection was achieved based on the MET-uptake area, in contrast to T2WI-based partial resection (65%), because the T2WI+/MET- area defined the language area. Pathological findings showed that the T2WI+/MET+ area is glioma, whereas 6 of 9 T2WI+/MET- lesions included normal tissues. Tissue from T2W1+/MET+/FDG+/GdMRI+ lesions gave an accurate diagnosis of grade in six cases. Non- or minimally enhancing gliomas were classified as having a MET uptake area that totally or partially overlapped with the T2WI hyperintense area. Resection planning with or without a metabolically active area in non- or minimally enhancing gliomas may be useful for accurate diagnosis, malignancy grading, and particularly for eloquent area although further study is needed to analyze the T2WI+/MET- area.
引用
收藏
页码:537 / 548
页数:12
相关论文
共 50 条
  • [1] A surgical strategy using a fusion image constructed from 11C-methionine PET, 18F-FDG-PET and MRI for glioma with no or minimum contrast enhancement
    Makoto Ideguchi
    Takafumi Nishizaki
    Norio Ikeda
    Tomomi Okamura
    Yasue Tanaka
    Natsumi Fujii
    Machiko Ohno
    Taichi Shimabukuro
    Tokuhiro Kimura
    Eiji Ikeda
    Kazuyoshi Suga
    Journal of Neuro-Oncology, 2018, 138 : 537 - 548
  • [2] 11C-Acetate PET in the Evaluation of Brain Glioma: Comparison with 11C-Methionine and 18F-FDG-PET
    Y. Yamamoto
    Y. Nishiyama
    N. Kimura
    R. Kameyama
    N. Kawai
    T. Hatakeyama
    M. Kaji
    M. Ohkawa
    Molecular Imaging and Biology, 2008, 10
  • [3] 11C-acetate PET in the evaluation of brain glioma:: Comparison with 11C-methionine and 18F-FDG-PET
    Yamamoto, Y.
    Nishiyama, Y.
    Kimura, N.
    Kameyama, R.
    Kawai, N.
    Hatakeyama, T.
    Kaji, M.
    Ohkawa, M.
    MOLECULAR IMAGING AND BIOLOGY, 2008, 10 (05) : 281 - 287
  • [4] 11C-Methionine PET for Grading and Prognostication in Gliomas: A Comparison Study with 18F-FDG PET and Contrast Enhancement on MRI
    Singhal, Tarun
    Narayanan, Tanjore K.
    Jacobs, Martin P.
    Bal, Chandrashekhar
    Mantil, Joseph C.
    JOURNAL OF NUCLEAR MEDICINE, 2012, 53 (11) : 1709 - 1715
  • [5] 11C-methionine PET as a prognostic marker in patients with glioma: comparison with 18F-FDG PET
    Sungeun Kim
    June-Key Chung
    So-Hyang Im
    Jae Min Jeong
    Dong Soo Lee
    Dong Gyu Kim
    Hee Won Jung
    Myung Chul Lee
    European Journal of Nuclear Medicine and Molecular Imaging, 2005, 32 : 52 - 59
  • [6] 11C-methionine PET as a prognostic marker in patients with glioma:: comparison with 18F-FDG PET
    Kim, S
    Chung, JK
    Im, SH
    Jeong, JM
    Lee, DS
    Kim, DG
    Jung, HW
    Lee, MC
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2005, 32 (01) : 52 - 59
  • [7] Validation for performing 11C-methionine and 18F-FDG-PET studies on the same day
    Mitsumoto, Takuya
    Kubota, Kazuo
    Sato, Takashi
    Morooka, Miyako
    Minamimoto, Ryogo
    Shimbo, Takuro
    Muramatsu, Yoshihisa
    Sasaki, Toru
    Ito, Kimiteru
    Fukushi, Masahiro
    NUCLEAR MEDICINE COMMUNICATIONS, 2012, 33 (03) : 297 - 304
  • [8] Clinical use of 11C-methionine and 18F-FDG-PET for germinoma in central nervous system
    Okochi, Yoshiyuki
    Nihashi, Takashi
    Fujii, Masazumi
    Kato, Katsuhiko
    Okada, Yumiko
    Ando, Yoshio
    Maesawa, Satoshi
    Takebayashi, Shigenori
    Wakabayashi, Toshihiko
    Naganawa, Shinji
    ANNALS OF NUCLEAR MEDICINE, 2014, 28 (02) : 94 - 102
  • [9] Clinical use of 11C-methionine and 18F-FDG-PET for germinoma in central nervous system
    Yoshiyuki Okochi
    Takashi Nihashi
    Masazumi Fujii
    Katsuhiko Kato
    Yumiko Okada
    Yoshio Ando
    Satoshi Maesawa
    Shigenori Takebayashi
    Toshihiko Wakabayashi
    Shinji Naganawa
    Annals of Nuclear Medicine, 2014, 28 : 94 - 102
  • [10] Performance of 18F-FDG, 11C-Methionine, and 18F-FET PET for Glioma Grading A Meta-analysis
    Katsanos, Aristeidis H.
    Alexiou, George A.
    Fotopoulos, Andreas D.
    Jabbour, Pascal
    Kyritsis, Athanasios P.
    Sioka, Chrissa
    CLINICAL NUCLEAR MEDICINE, 2019, 44 (11) : 864 - 869